Skip to content

News & Events

Academic Urology Research Investigators Consortium (AURIC)

Explore AURIC

AURIC Home
Institutions & Investigators
About
Facts

Explore Oncology Consortia

Myeloma (AMyC)
Breast Cancer (ABRCC)
Thoracic Oncology (ATOMIC)
GI Cancer (AGICC)
AURIC Investigator’s Meeting – Successful First Meeting of Newly Formed Group
The Academic Urology Research Investigators Consortium met for an initial Investigator’s Meeting during the recent GU-ASCO 2023 in San Francisco to explore new studies for the coming year. The group’s primary focus is to partner with pharmaceutical companies looking to explore novel genitourinary oncology trials.
Thomas Flaig, MD
Management of toxicities with novel systemic therapies in UC
AURIC Director Thomas Flaig, MD, of the University of Colorado Anschutz Medical Campus in Aurora, Colorado, provides an overview of the management of toxicities with novel systemic therapies in patients with urothelial carcinoma (UC), highlighting the use of antibody-drug conjugates in advanced disease.